Edward L. Murphy's most recent trade in Co-Diagnostics Inc was a trade of 1,695 Common Stock done . Disclosure was reported to the exchange on May 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Co-Diagnostics Inc | Edward L. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2026 | 1,695 | 11,084 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Edward L. Murphy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2026 | 1,695 | 4,000 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | Edward L. Murphy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2025 | 57,499 | 170,834 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | Edward L. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2025 | 57,499 | 281,666 (1%) | 0% | 0 | Common Stock |